Point72 Ventures
- 3
- Portfolio companies on reccy
- 1
- Hiring now
- 12
- Open roles in the portfolio
- Aug 2026
- Latest portfolio round
Hiring now in the portfolio12
Apply on each company's site- Posted 5d ago
Senior Director, Data Management
Alto Neuroscience · Mountain View, CA
- Posted 24d ago
Senior Manager, Clinical Operations: People & Functional Leadership
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
Senior Manager/Director of Contracts and Procurement
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
Manager, Patient Recruitment & Engagement
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
VP, Commercial Planning
Alto Neuroscience · Mountain View, CA
- Posted 1mo ago
Clinical Trial Associate
Alto Neuroscience · Mountain View, CA
- Posted 2mo ago
Associate Director, Clinical Operations: People & Functional Leadership
Alto Neuroscience · Mountain View, CA
- Posted 2mo ago
Manager, Clinical Science & Site Educator
Alto Neuroscience · Remote (US)
Portfolio on reccy3
From company funding records- Series C · $45M · Nov 202312 roles
Alto Neuroscience
Los Altos, CA · Led a round · Series C · $45M · Nov 2023
- Seed · $2.7M · Aug 2026None
BEACON-Neuro.AI Inc.
St. Louis, Missouri, United States · Led a round · Seed · $2.7M · Aug 2026
- Venture Round · $10.4M · Feb 2024None
Nia Therapeutics
Radnor, Pennsylvania · Led a round · Venture Round · $10.4M · Feb 2024
Their companies, round by round
From company funding records- Alto NeuroscienceLos Altos, CA
- Jul 2026Post-IPO Equity (PIPE) · $100M
- Mar 2026Post-IPO Equity (PIPE) · $120M
- Oct 2025Post-IPO Equity (PIPE) · $50M
- Jul 2024Grant · $11.7M
- Nov 2023Venture Round · $59.3M
- Nov 2023Series C · $45MLed
- BEACON-Neuro.AI Inc.St. Louis, Missouri, United States
- Aug 2026Pre-Seed · $500K
- Aug 2026Seed · $2.7MLed
- Mar 2026Series A · $32M
- Nia TherapeuticsRadnor, Pennsylvania
Brain-computer interfaces · Neuromodulation
- Jun 2026Later Stage VC · $26.5M
- Feb 2024Venture Round · $10.4MLed
- Dec 2021Seed · $23.6M
- Dec 2021Series A · $6.6M
- Jan 2021Accelerator/Incubator
- Sep 2020Debt
Rounds marked Led list Point72 Ventures as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Aug 2026
BEACON-Neuro.AI Inc. · Seed $2.7MLead
- Feb 2024
Nia Therapeutics · Venture Round $10.4MLead
- Nov 2023
Alto Neuroscience · Series C $45MLead
With InVivium Capital, Franklin Templeton, Eli Lilly and Company, Alexandria Venture Investments
Portfolio in the news
From the Cortex · last 12 months- Mar 2026
- Jan 2026
- Jan 2026Nia Therapeutics Publishes In Vivo SNS Validation Data
Nia Therapeutics · medicaldevice-network.com
- Jan 2026